{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T10:17:12Z","timestamp":1794997032681,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hebrew University of Jerusalem","id":[{"id":"https:\/\/ror.org\/03qxff017","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is an inhibitory receptor expressed by multiple tumors, including colorectal cancer (CRC). CEACAM1 exists as a long isoform (L) containing immunoreceptor tyrosine-based inhibitory motifs (ITIMs) and a short isoform (S) lacking ITIMs. While microsatellite instability (MSI) CRCs respond to immunotherapy, microsatellite-stable (MSS) CRCs remain resistant, highlighting the need for alternative therapeutic targets. We previously developed an agonistic anti-CEACAM1 monoclonal antibody (mAb), CCM5.01, and demonstrated its CEACAM1-dependent inhibitory effects in melanoma. Here, we evaluated CCM5.01 inhibitory activity on CRC cell lines and related it to L\/S ratio.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>CRC cell lines HT-29, LOVO, and HCT-116 were treated with CCM5.01 and analyzed by proliferation assays before and after transfection with L or S CEACAM1 isoforms. Transfected cells treated with CCM5.01 were analyzed for signaling and in 3D spheroid models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CEACAM1-positive CRC cells showed dose-dependent inhibition in response to CCM5.01 treatment and were associated with L\/S isoform expression. High CEACAM1-L expression induced growth inhibition and apoptosis, while CEACAM1-S promoted cellular activity. Similar isoform-dependent effects were observed in spheroid models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CEACAM1-mediated signaling in CRCs critically depends on the L\/S isoform ratio, supporting CEACAM1-targeted activating therapy as a potential strategy in both MSI and immunotherapy-resistant MSS CRC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s43440-026-00891-1","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T08:18:57Z","timestamp":1788164337000},"page":"1566-1578","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The anti-CEACAM1 agonistic antibody CCM5.01 inhibits the growth of colon cancer cell lines in 2D and 3D models"],"prefix":"10.1007","volume":"78","author":[{"given":"Shiran","family":"Niazov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilan","family":"Zaffran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ofra","family":"Benny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha","family":"Ben-Zimra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0620-2810","authenticated-orcid":false,"given":"Francesca","family":"Levi-Schaffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"891_CR1","doi-asserted-by":"publisher","unstructured":"Labianca R, Beretta GD, Kildani B, Milesi L, Merlin F, Mosconi S, et al. Colon cancer. Crit Rev Oncol Hematol. 2010;106\u201333. https:\/\/doi.org\/10.1016\/j.critrevonc.2010.01.010.","DOI":"10.1016\/j.critrevonc.2010.01.010"},{"key":"891_CR2","doi-asserted-by":"crossref","unstructured":"Pawlik TM, Raut CP, Rodriguez-Bigas MA. Colorectal carcinogenesis: MSI-H versus MSI-L. Dis. Markers. IOS; 2004.","DOI":"10.1155\/2004\/368680"},{"key":"891_CR3","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","volume":"26","author":"M Chalabi","year":"2020","unstructured":"Chalabi M, Fanchi LF, Dijkstra KK, Van den Berg JG, Aalbers AG, Sikorska K, et al. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nat Med Nat Res. 2020;26:566\u201376. https:\/\/doi.org\/10.1038\/s41591-020-0805-8.","journal-title":"Nat Med Nat Res"},{"key":"891_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1112276","author":"J Ros","year":"2023","unstructured":"Ros J, Balconi F, Baraibar I, Saoudi Gonzalez N, Salva F, Tabernero J, et al. Advances in immune checkpoint inhibitor combination strategies for microsatellite stable colorectal cancer. Front Oncol Front Media S. 2023. https:\/\/doi.org\/10.3389\/fonc.2023.1112276.","journal-title":"Front Oncol Front Media S"},{"key":"891_CR5","doi-asserted-by":"publisher","unstructured":"Helfrich I, Singer BB. Size matters: The functional role of the CEACAM1 isoform signature and its impact for NK cell-mediated killing in melanoma. Cancers (Basel). MDPI AG; 2019. https:\/\/doi.org\/10.3390\/cancers11030356.","DOI":"10.3390\/cancers11030356"},{"key":"891_CR6","doi-asserted-by":"crossref","unstructured":"Singer BB, Scheffrahn I, Heymann R, Sigmundsson K, Kammerer R, Brink, BO\u00a8. Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Expression and Signaling in Human, Mouse, and Rat Leukocytes: Evidence for Replacement of the Short Cytoplasmic Domain Isoform by Glycosylphosphatidylinositol-Linked Proteins in Human Leukocytes 1 [Internet]. The Journal of Immunology. 2002. http:\/\/journals.aai.org\/jimmunol\/article-pdf\/168\/10\/5139\/1317708\/5139.pdf","DOI":"10.4049\/jimmunol.168.10.5139"},{"key":"891_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2019.101296","author":"WM Kim","year":"2019","unstructured":"Kim WM, Huang YH, Gandhi A, Blumberg RS, Academic Press. CEACAM1 structure and function in immunity and its therapeutic implications. Semin Immunol. 2019. https:\/\/doi.org\/10.1016\/j.smim.2019.101296.","journal-title":"Semin Immunol"},{"key":"891_CR8","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499:214\u20138. https:\/\/doi.org\/10.1038\/nature12213.","journal-title":"Nature"},{"key":"891_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3109\/10428194.2014.913287","volume":"56","author":"W Zhao","year":"2015","unstructured":"Zhao W, Zhang Y, Liu D, Zhong L, He Q, Zhao Y. Abnormal expression of CD66a promotes proliferation and inhibits apoptosis of human leukemic B cells in vitro. Leuk Lymphoma Informa Healthc. 2015;56:202\u201310. https:\/\/doi.org\/10.3109\/10428194.2014.913287.","journal-title":"Leuk Lymphoma Informa Healthc"},{"key":"891_CR10","doi-asserted-by":"publisher","unstructured":"Xu X, Masubuchi T, Cai Q, Zhao Y, Hui E. Molecular features underlying differential SHP1\/SHP2 binding of immune checkpoint receptors. 2021;10:74276. https:\/\/doi.org\/10.7554\/eLife","DOI":"10.7554\/eLife"},{"key":"891_CR11","doi-asserted-by":"publisher","unstructured":"Beauchemin N, Arabzadeh A. Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis. Cancer Metastasis Rev. 2013;643\u201371. https:\/\/doi.org\/10.1007\/s10555-013-9444-6.","DOI":"10.1007\/s10555-013-9444-6"},{"key":"891_CR12","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1158\/1535-7163.MCT-11-0526","volume":"11","author":"R Ortenberg","year":"2012","unstructured":"Ortenberg R, Sapir Y, Raz L, Hershkovitz L, Arav A, Ben, Sapoznik S, et al. Novel immunotherapy for malignant melanoma with a monoclonal antibody that blocks CEACAM1 homophilic interactions. Mol Cancer Ther. 2012;11:1300\u201310. https:\/\/doi.org\/10.1158\/1535-7163.MCT-11-0526.","journal-title":"Mol Cancer Ther"},{"key":"891_CR13","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/ijc.26072","volume":"129","author":"J Ieda","year":"2011","unstructured":"Ieda J, Yokoyama S, Tamura K, Takifuji K, Hotta T, Matsuda K, et al. Re-expression of CEACAM1 long cytoplasmic domain isoform is associated with invasion and migration of colorectal cancer. Int J Cancer. 2011;129:1351\u201361. https:\/\/doi.org\/10.1002\/ijc.26072.","journal-title":"Int J Cancer"},{"key":"891_CR14","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1038\/s41417-022-00486-x","volume":"29","author":"I Zaffran","year":"2022","unstructured":"Zaffran I, Landolina N, Gaur P, Rovis TL, Stipan J, Mandelboim O, et al. Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells. Cancer Gene Ther Springer Nat. 2022;29:1676\u201385. https:\/\/doi.org\/10.1038\/s41417-022-00486-x.","journal-title":"Cancer Gene Ther Springer Nat"},{"key":"891_CR15","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1111\/all.13730","volume":"74","author":"F Legrand","year":"2019","unstructured":"Legrand F, Landolina N, Zaffran I, Emeh RO, Chen E, Klion AD, et al. Siglec-7 on peripheral blood eosinophils: Surface expression and function. Allergy: Eur J Allergy Clin Immunol Blackwell Publishing Ltd. 2019;74:1257\u201365. https:\/\/doi.org\/10.1111\/all.13730.","journal-title":"Allergy: Eur J Allergy Clin Immunol Blackwell Publishing Ltd"},{"key":"891_CR16","doi-asserted-by":"publisher","unstructured":"Ahmed D, Eide PW, Eilertsen IA, Danielsen SA, Ekn\u00e6s M, Hektoen M, et al. Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis. 2013;2. https:\/\/doi.org\/10.1038\/oncsis.2013.35.","DOI":"10.1038\/oncsis.2013.35"},{"key":"891_CR17","doi-asserted-by":"crossref","unstructured":"Arabzadeh A, Mcgregor K, Breton V, Van Der Kraak L, Akavia UD, Greenwood CMT et al. EphA2 signaling is impacted by carcinoembryonic antigen cell adhesion molecule 1-L expression in colorectal cancer liver metastasis in a cell context-dependent manner [Internet]. 2017. www.impactjournals.com\/oncotarget","DOI":"10.18632\/oncotarget.22236"},{"key":"891_CR18","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/sj.bjc.6601316","volume":"89","author":"A Fedier","year":"2003","unstructured":"Fedier A, Fowst C, Tursi J, Geroni C, Haller U, Marchini S, et al. Brostallicin (PNU-166196) - A new DNa minor groove binder that retains sensitivity in DNa mismatch repair-deficient tumour cells. Br J Cancer Nat Publishing Group. 2003;89:1559\u201365. https:\/\/doi.org\/10.1038\/sj.bjc.6601316.","journal-title":"Br J Cancer Nat Publishing Group"},{"key":"891_CR19","unstructured":"Singer BB, Scheffrahn I, Brink BO\u00a8. The Tumor Growth-inhibiting Cell Adhesion Molecule CEACAM1 (C-CAM) Is Differently Expressed in Proliferating and Quiescent Epithelial Cells and Regulates Cell Proliferation 1 [Internet]. Cancer Res. 2000. http:\/\/aacrjournals.org\/cancerres\/article-pdf\/60\/5\/1236\/3241171\/ch050001236p.pdf"},{"key":"891_CR20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1245\/s10434-013-3460-1","volume":"21","author":"S Kiriyama","year":"2014","unstructured":"Kiriyama S, Yokoyama S, Ueno M, Hayami S, Ieda J, Yamamoto N, et al. CEACAM1 Long Cytoplasmic Domain Isoform is Associated with Invasion and Recurrence of Hepatocellular Carcinoma. Ann Surg Oncol Springer New York LLC. 2014;21:505\u201314. https:\/\/doi.org\/10.1245\/s10434-013-3460-1.","journal-title":"Ann Surg Oncol Springer New York LLC"},{"key":"891_CR21","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/cam4.1050","volume":"6","author":"C Ueshima","year":"2017","unstructured":"Ueshima C, Kataoka TR, Takei Y, Hirata M, Sugimoto A, Hirokawa M, et al. CEACAM1 long isoform has opposite effects on the growth of human mastocytosis and medullary thyroid carcinoma cells. Cancer Med Blackwell Publishing Ltd. 2017;6:845\u201356. https:\/\/doi.org\/10.1002\/cam4.1050.","journal-title":"Cancer Med Blackwell Publishing Ltd"},{"key":"891_CR22","doi-asserted-by":"publisher","first-page":"ii23","DOI":"10.1093\/annonc\/mdv093.2","volume":"26","author":"T Ben-Moshe","year":"2015","unstructured":"Ben-Moshe T, Sapir Y, Mandel I, Hakim M, Hashmueli S, Markel G. Inhibition of the novel immune checkpoint CEACAM1 enhances anti-tumor activity. Annals Oncol Elsevier BV. 2015;26:ii23. https:\/\/doi.org\/10.1093\/annonc\/mdv093.2.","journal-title":"Annals Oncol Elsevier BV"},{"key":"891_CR23","doi-asserted-by":"publisher","unstructured":"Barrow AD, Trowsdale J. You say ITAM and I say ITIM, let\u2019s call the whole thing off: The ambiguity of immunoreceptor signalling. Eur J Immunol. 2006;1646\u201353. https:\/\/doi.org\/10.1002\/eji.200636195.","DOI":"10.1002\/eji.200636195"},{"key":"891_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1006\/smim.2000.0223","volume":"12","author":"J Zhang","year":"2000","unstructured":"Zhang J, Somani AK, Siminovitch KA. Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling. Semin Immunol Acad Press. 2000;12:361\u201378. https:\/\/doi.org\/10.1006\/smim.2000.0223.","journal-title":"Semin Immunol Acad Press"},{"key":"891_CR25","doi-asserted-by":"publisher","unstructured":"Walls J, Sinclair L, Finlay D. Nutrient sensing, signal transduction and immune responses. Semin. Immunol. Academic Press; 2016. pp. 396\u2013407. https:\/\/doi.org\/10.1016\/j.smim.2016.09.001","DOI":"10.1016\/j.smim.2016.09.001"},{"key":"891_CR26","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.immuni.2006.08.026","volume":"25","author":"T Nagaishi","year":"2006","unstructured":"Nagaishi T, Pao L, Lin SH, Iijima H, Kaser A, Qiao SW, et al. SHP1 Phosphatase-Dependent T Cell Inhibition by CEACAM1 Adhesion Molecule Isoforms. Immunity. 2006;25:769\u201381. https:\/\/doi.org\/10.1016\/j.immuni.2006.08.026.","journal-title":"Immunity"},{"key":"891_CR27","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1002\/eji.201242676","volume":"43","author":"S Hosomi","year":"2013","unstructured":"Hosomi S, Chen Z, Baker K, Chen L, Huang YH, Olszak T, et al. CEACAM1 on activated NK cells inhibits NKG2D-mediated cytolytic function and signaling. Eur J Immunol. 2013;43:2473\u201383. https:\/\/doi.org\/10.1002\/eji.201242676.","journal-title":"Eur J Immunol"},{"key":"891_CR28","doi-asserted-by":"publisher","unstructured":"Sappino AP, Buser R, Seguin Q, Fernet M, Lesne L, Gumy-Pause F, et al. The CEACAM1 tumor suppressor is an ATM and p53-regulated gene required for the induction of cellular senescence by DNA damage. Oncogenesis. 2012;1. https:\/\/doi.org\/10.1038\/oncsis.2012.7.","DOI":"10.1038\/oncsis.2012.7"},{"key":"891_CR29","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/978-1-4939-1804-1_31","volume-title":"Risk Assessment, Diagnosis, Treatment, and Prognosis","author":"A Mishra","year":"2014","unstructured":"Mishra A, Brat DJ, Verma M. P53 tumor suppression network in cancer epigenetics. Cancer Epigenetics. Risk Assessment, Diagnosis, Treatment, and Prognosis. New York: Springer; 2014. pp. 597\u2013605. https:\/\/doi.org\/10.1007\/978-1-4939-1804-1_31."},{"key":"891_CR30","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3892\/or.2017.5813","volume":"38","author":"W Yansheng","year":"2017","unstructured":"Yansheng W, Liu C, Jianchun W, Yang Z, Chen L. Iodine-131 induces apoptosis in human cardiac muscle cells through the p53\/Bax\/caspase-3 and PIDD\/caspase-2\/ t-BID\/cytochrome c\/caspase-3 signaling pathway. Oncol Rep Spandidos Publications. 2017;38:1579\u201386. https:\/\/doi.org\/10.3892\/or.2017.5813.","journal-title":"Oncol Rep Spandidos Publications"},{"key":"891_CR31","doi-asserted-by":"publisher","unstructured":"Xu X, Farach-Carson MC, Jia X. Three-dimensional in vitro tumor models for cancer research and drug evaluation. Biotechnol. Adv. Elsevier Inc.; 2014. pp. 1256\u201368. https:\/\/doi.org\/10.1016\/j.biotechadv.2014.07.009.","DOI":"10.1016\/j.biotechadv.2014.07.009"},{"key":"891_CR32","doi-asserted-by":"publisher","first-page":"S388","DOI":"10.4103\/0973-1482.176170","volume":"14","author":"YC Chung","year":"2018","unstructured":"Chung YC, Chiang HC, Chang H, Lin CC, Lo LT, Wang AY, et al. Longan flower proanthocyanidins induce apoptosis in HT-29 colorectal carcinoma spheroids. J Cancer Res Ther Wolters Kluwer Medknow Publications. 2018;14:S388\u201393. https:\/\/doi.org\/10.4103\/0973-1482.176170.","journal-title":"J Cancer Res Ther Wolters Kluwer Medknow Publications"},{"key":"891_CR33","doi-asserted-by":"publisher","unstructured":"D\u2019angelo E, Natarajan D, Sensi F, Ajayi O, Fassan M, Mammano E, et al. Patient-derived scaffolds of colorectal cancer metastases as an organotypic 3D model of the liver metastatic microenvironment. Cancers (Basel) MDPI AG. 2020;12. https:\/\/doi.org\/10.3390\/cancers12020364.","DOI":"10.3390\/cancers12020364"},{"key":"891_CR34","doi-asserted-by":"publisher","unstructured":"Terzi\u0107 J, Grivennikov S, Karin E, Karin M. Inflammation and Colon Cancer. Gastroenterology. W.B. Saunders; 2010. p. 138. https:\/\/doi.org\/10.1053\/j.gastro.2010.01.058.","DOI":"10.1053\/j.gastro.2010.01.058"},{"key":"891_CR35","doi-asserted-by":"publisher","unstructured":"Waugh DJJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res. 2008;6735\u201341. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-4843.","DOI":"10.1158\/1078-0432.CCR-07-4843"},{"key":"891_CR36","doi-asserted-by":"publisher","unstructured":"Bazzichetto C, Milella M, Zampiva I, Simionato F, Amoreo CA, Buglioni S, et al. Interleukin-8 in Colorectal Cancer: A Systematic Review and Meta-Analysis of Its Potential Role as a Prognostic Biomarker. Biomedicines MDPI. 2022;10. https:\/\/doi.org\/10.3390\/biomedicines10102631.","DOI":"10.3390\/biomedicines10102631"},{"key":"891_CR37","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1158\/0008-5472.CAN-16-1602","volume":"77","author":"M Fang","year":"2017","unstructured":"Fang M, Li Y, Huang K, Qi S, Zhang J, Zgodzinski W, et al. IL33 promotes colon cancer cell stemness via JNK activation and macrophage recruitment. Cancer Res Am Association Cancer Res Inc. 2017;77:2735\u201345. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-1602.","journal-title":"Cancer Res Am Association Cancer Res Inc"},{"key":"891_CR38","doi-asserted-by":"publisher","unstructured":"Akimoto M, Takenaga K. Role of the IL-33\/ST2L axis in colorectal cancer progression. Cell Immunol Acad Press Inc. 2019;343. https:\/\/doi.org\/10.1016\/j.cellimm.2017.12.014.","DOI":"10.1016\/j.cellimm.2017.12.014"},{"key":"891_CR39","doi-asserted-by":"publisher","unstructured":"Zhu Y, Song D, Song Y, Wang X. Interferon gamma induces inflammatory responses through the interaction of CEACAM1 and PI3K in airway epithelial cells. J Transl Med BioMed Cent Ltd. 2019;17. https:\/\/doi.org\/10.1186\/s12967-019-1894-3.","DOI":"10.1186\/s12967-019-1894-3"},{"key":"891_CR40","doi-asserted-by":"publisher","unstructured":"Sanmamed MF, Perez-Gracia JL, Schalper KA, Fusco JP, Gonzalez A, Rodriguez-Ruiz ME, et al. Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients. Annals of Oncology. Volume 28. Oxford University Press; 2017. pp. 1988\u201395. https:\/\/doi.org\/10.1093\/annonc\/mdx190.","DOI":"10.1093\/annonc\/mdx190"},{"key":"891_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.723846","author":"X Xiong","year":"2022","unstructured":"Xiong X, Liao X, Qiu S, Xu H, Zhang S, Wang S, et al. CXCL8 in Tumor Biology and Its Implications for Clinical Translation. Front Mol Biosci Front Media S A. 2022. https:\/\/doi.org\/10.3389\/fmolb.2022.723846.","journal-title":"Front Mol Biosci Front Media S A"},{"key":"891_CR42","doi-asserted-by":"publisher","unstructured":"Horst AK, Wegscheid C, Schaefers C, Schiller B, Neumann K, Lunemann S et al. Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Controls IL-2-Dependent Regulatory T-cell Induction in Immune-Mediated Hepatitis in Mice. 2018; https:\/\/doi.org\/10.1002\/hep.29812\/suppinfo","DOI":"10.1002\/hep.29812\/suppinfo"},{"key":"891_CR43","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.immuni.2012.07.016","volume":"37","author":"L Chen","year":"2012","unstructured":"Chen L, Chen Z, Baker K, Halvorsen EM, Pires da Cunha A, Flak MB, et al. The Short Isoform of the CEACAM1 Receptor in Intestinal T Cells Regulates Mucosal Immunity and Homeostasis via Tfh Cell Induction. Immunity. 2012;37:930\u201346. https:\/\/doi.org\/10.1016\/j.immuni.2012.07.016.","journal-title":"Immunity"},{"key":"891_CR44","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1083\/jcb.200904150","volume":"187","author":"MM M\u00fcller","year":"2009","unstructured":"M\u00fcller MM, Klaile E, Vorontsova O, Singer BB, \u00d6brink B. Homophilic adhesion and CEACAM1-S regulate dimerization of CEACAM1-L and recruitment of SHP-2 and c-Src. J Cell Biol. 2009;187:569\u201381. https:\/\/doi.org\/10.1083\/jcb.200904150.","journal-title":"J Cell Biol"},{"key":"891_CR45","unstructured":"Izzi L, Turbide C, Houde C, Kunath T, Beauchemin N. cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function [Internet]. http:\/\/www.stockton-press.co.uk\/onc"},{"key":"891_CR46","doi-asserted-by":"publisher","unstructured":"Purdy AK, Campbell KS. Natural killer cells and cancer: Regulation by the killer cell ig-like receptors (KIR). Cancer Biol Ther Landes Bioscience. 2009;2209\u201318. https:\/\/doi.org\/10.4161\/cbt.8.23.10455.","DOI":"10.4161\/cbt.8.23.10455"},{"key":"891_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01393","author":"F Junker","year":"2020","unstructured":"Junker F, Gordon J, Qureshi O. Fc Gamma Receptors and Their Role in Antigen Uptake, Presentation, and T Cell Activation. Front Immunol Front Media S A. 2020. https:\/\/doi.org\/10.3389\/fimmu.2020.01393.","journal-title":"Front Immunol Front Media S A"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00891-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-026-00891-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00891-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T09:25:13Z","timestamp":1794993913000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-026-00891-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["891"],"URL":"https:\/\/doi.org\/10.1007\/s43440-026-00891-1","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study involved only established cell lines and did not involve human subjects or animals. Ethical approval was therefore not required.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}